Company intelligence / Profile preview

Suzhou Shanbai Biotechnology

Suzhou, Jiangsu, Chinajunshipharma.com ↗

Overview

No clinical results or pipeline data found for this company.

1 asset

Commercial

Indications: Melanoma, Nasopharyngeal carcinoma, Urothelial carcinoma, Non-small cell lung cancer, Esophageal squamous cell carcinoma, Renal cell carcinoma, Small cell lung cancer, Triple-negative breast cancer, Hepatocellular carcinoma

Beyond the preview

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Follow clinical development from trial design and recruitment through results.

Explore licensing agreements, acquisitions, and the assets behind each deal.

Trace financing activity and the investors behind a company’s development.

Compare peer pipelines by target, modality, and therapeutic area.

Explore technology platforms and the patent landscape around relevant assets.

Connect company news and source material to the questions you’re investigating.

See how Gosset can support your research on Suzhou Shanbai Biotechnology.